Penumbra 관리

관리 기준 확인 4/4

Penumbra CEO는 Adam Elsesser, Jun2004 에 임명되었습니다 의 임기는 20.42 년입니다. 총 연간 보상은 $ 601.62K, 99.7% 로 구성됩니다. 99.7% 급여 및 0.3% 보너스(회사 주식 및 옵션 포함). 는 $ 206.90M 가치에 해당하는 회사 주식의 2.27% 직접 소유합니다. 206.90M. 경영진과 이사회의 평균 재임 기간은 각각 4.5 년과 8.7 년입니다.

주요 정보

Adam Elsesser

최고 경영자

US$601.6k

총 보상

CEO 급여 비율	99.7%
CEO 임기	20.4yrs
CEO 소유권	2.3%
경영진 평균 재임 기간	4.5yrs
이사회 평균 재임 기간	8.7yrs

최근 관리 업데이트

Recent updates

Penumbra, Inc. (NYSE:PEN) Shares Could Be 23% Above Their Intrinsic Value Estimate

Jul 11

Returns At Penumbra (NYSE:PEN) Appear To Be Weighed Down

Jun 19

Penumbra: Appeal Improves As Operating Leverage Continues

May 30

Penumbra, Inc.'s (NYSE:PEN) Earnings Haven't Escaped The Attention Of Investors

Apr 12

Estimating The Intrinsic Value Of Penumbra, Inc. (NYSE:PEN)

Mar 21

Some Investors May Be Worried About Penumbra's (NYSE:PEN) Returns On Capital

Jan 23

A Look At The Fair Value Of Penumbra, Inc. (NYSE:PEN)

Nov 16

Penumbra: Appeal Improves, Just Not Appealing Yet

Oct 16

Returns On Capital Signal Tricky Times Ahead For Penumbra (NYSE:PEN)

Oct 05

Penumbra: Consolidation Does Nothing To Change Long-Term Thesis, Reiterate Buy

Sep 01

A Look At The Intrinsic Value Of Penumbra, Inc. (NYSE:PEN)

Aug 15

Penumbra (NYSE:PEN) Has Some Way To Go To Become A Multi-Bagger

Jun 28

Penumbra: Future Upside Drivers In Fundamental, Sentimental And Valuation Factors

Jun 22

Getting In Cheap On Penumbra, Inc. (NYSE:PEN) Might Be Difficult

Jun 02

We're Not Worried About Penumbra's (NYSE:PEN) Cash Burn

Apr 01

Penumbra Non-GAAP EPS of $0.16 beats by $0.01, revenue of $221.22M beats by $4.19M

Feb 23

Penumbra Riding Higher On Upcoming Launches And Rerating

Jan 12

Penumbra: Today's Best Medical Equipment Nearby Cap-Gain Buy

Nov 03

Penumbra cut to Neutral at Citi on macro concerns

Oct 05

Penumbra, Asahi team up to bring blood clot removing device Indigo to Japan

Sep 22

CEO 보상 분석

Adam Elsesser 의 보수는 Penumbra 의 수익과 비교하여 어떻게 변경되었나요?
날짜	총 보상	급여	회사 수익
Sep 30 2024	n/a	n/a	US$35m
Jun 30 2024	n/a	n/a	US$14m
Mar 31 2024	n/a	n/a	US$93m
Dec 31 2023	US$602k	US$600k	US$91m
Sep 30 2023	n/a	n/a	US$41m
Jun 30 2023	n/a	n/a	US$29m
Mar 31 2023	n/a	n/a	US$6m
Dec 31 2022	US$602k	US$600k	-US$2m
Sep 30 2022	n/a	n/a	-US$31m
Jun 30 2022	n/a	n/a	-US$19m
Mar 31 2022	n/a	n/a	-US$6m
Dec 31 2021	US$498k	US$496k	US$5m
Sep 30 2021	n/a	n/a	US$34m
Jun 30 2021	n/a	n/a	US$16m
Mar 31 2021	n/a	n/a	-US$5m
Dec 31 2020	US$219k	US$217k	-US$16m
Sep 30 2020	n/a	n/a	-US$10m
Jun 30 2020	n/a	n/a	US$11m
Mar 31 2020	n/a	n/a	US$39m
Dec 31 2019	US$727k	US$725k	US$48m
Sep 30 2019	n/a	n/a	US$45m
Jun 30 2019	n/a	n/a	US$15m
Mar 31 2019	n/a	n/a	US$12m
Dec 31 2018	US$727k	US$725k	US$7m
Sep 30 2018	n/a	n/a	US$9m
Jun 30 2018	n/a	n/a	US$28m
Mar 31 2018	n/a	n/a	US$13m
Dec 31 2017	US$727k	US$725k	US$5m

보상 대 시장: Adam 의 총 보상 ($USD 601.62K ) US 시장에서 비슷한 규모의 회사에 대한 평균보다 낮습니다( $USD 7.94M ).

보상과 수익: Adam 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.

CEO

Adam Elsesser (62 yo)

20.4yrs

테뉴어

US$601,620

보상

Mr. Adam Elsesser serves as President at Penumbra, Inc. since May 2020. He Co-Founded Penumbra, Inc. in 2004 and has been its Chief Executive Officer and Director since June 2004. Mr. Elsesser has been the...

리더십 팀

이름	위치	테뉴어	보상	소유권
Adam Elsesser	Co-Founder	20.4yrs	US$601.62k	2.27% $ 206.9m
Arani Bose	Co-Founder & Director	20.4yrs	US$233.99k	0.88% $ 80.0m
Maggie Yuen	Chief Financial Officer	4.9yrs	US$666.04k	0.017% $ 1.5m
Lambert Shiu	Chief Accounting Officer	4.9yrs	US$539.94k	0.041% $ 3.7m
Johanna Roberts	Executive VP	6.2yrs	US$661.89k	0.13% $ 12.1m
Ben Sorci	Executive Vice President of Operations	3.8yrs	데이터 없음	데이터 없음
Pankaj Tiwari	Executive VP & Chief Information Officer	2.8yrs	데이터 없음	데이터 없음
Jee Hamlyn-Harris	Investor Relations Officer	no data	데이터 없음	데이터 없음
Ben Tompkins	Executive Vice President of Development & Compliance	less than a year	데이터 없음	데이터 없음
Shruthi Narayan	Executive VP & GM of Interventional	1.8yrs	데이터 없음	데이터 없음
Jason Mills	Executive Vice President of Strategy	4.5yrs	데이터 없음	데이터 없음
James Benenati	Chief Medical Officer	3.8yrs	데이터 없음	데이터 없음

4.5yrs

평균 재임 기간

52yo

평균 연령

경험이 풍부한 관리: PEN 의 관리팀은 경험 ( 4.5 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Adam Elsesser	Co-Founder	20.4yrs	US$601.62k	2.27% $ 206.9m
Arani Bose	Co-Founder & Director	20.4yrs	US$233.99k	0.88% $ 80.0m
Harpreet Grewal	Independent Director	9.6yrs	US$241.49k	0.022% $ 2.0m
Thomas Wilder	Independent Director	7.8yrs	US$258.99k	0.012% $ 1.1m
Don Kassing	Presiding Independent Director	16.8yrs	US$246.49k	0.024% $ 2.2m
Surbhi Sarna	Independent Director	5.3yrs	US$248.99k	0.0064% $ 583.3k
Bridget O'Rourke	Independent Director	7.6yrs	US$263.99k	0.011% $ 1.0m
Janet Leeds	Independent Director	5.8yrs	US$251.49k	0.013% $ 1.1m

8.7yrs

평균 재임 기간

60.5yo

평균 연령

경험이 풍부한 이사회: PEN 의 이사회는 경험(평균 재직 기간 8.7 년)으로 간주됩니다.

Penumbra 관리

관리 기준 확인 4/4

주요 정보

최근 관리 업데이트

Executive VP notifies of intention to sell stock

Co-Founder notifies of intention to sell stock

Co-Founder notifies of intention to sell stock

Penumbra, Inc., Annual General Meeting, Jun 05, 2024

Executive VP notifies of intention to sell stock

Executive VP notifies of intention to sell stock

Recent updates

Consensus EPS estimates fall by 48%

Penumbra, Inc. Reiterates Earnings Guidance for the Year 2024

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

Penumbra (NYSE:PEN) May Have Issues Allocating Its Capital

Penumbra, Inc. to Report Q3, 2024 Results on Oct 30, 2024

Executive VP notifies of intention to sell stock

Co-Founder notifies of intention to sell stock

Penumbra Grinding Through A Painful Growth Expectations Reset

Penumbra, Inc. (NYSE:PEN) announces an Equity Buyback for $200 million worth of its shares.

Consensus EPS estimates fall by 72%

What You Can Learn From Penumbra, Inc.'s (NYSE:PEN) P/S

Second quarter 2024 earnings: EPS misses analyst expectations

Penumbra, Inc. (NYSE:PEN) Shares Could Be 23% Above Their Intrinsic Value Estimate

Penumbra, Inc. to Report Q2, 2024 Results on Jul 30, 2024

Now 21% undervalued after recent price drop

Returns At Penumbra (NYSE:PEN) Appear To Be Weighed Down

Penumbra: Appeal Improves As Operating Leverage Continues

Co-Founder notifies of intention to sell stock

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Penumbra, Inc. Reiterates Earnings Guidance for the Year 2024

Penumbra, Inc., Annual General Meeting, Jun 05, 2024

Penumbra, Inc. Launches Lightning Flash 2.0 - Latest CAVT Technology Designed to Rapidly Remove Blood Clots

Penumbra, Inc.'s (NYSE:PEN) Earnings Haven't Escaped The Attention Of Investors

Penumbra, Inc. to Report Q1, 2024 Results on May 07, 2024

Estimating The Intrinsic Value Of Penumbra, Inc. (NYSE:PEN)

Executive VP notifies of intention to sell stock

Full year 2023 earnings: EPS exceeds analyst expectations

Penumbra, Inc. Provides Earnings Guidance for the Full Year 2024

Now 21% overvalued after recent price rise

Now 23% overvalued after recent price rise

Penumbra, Inc. to Report Q4, 2023 Results on Feb 22, 2024

Some Investors May Be Worried About Penumbra's (NYSE:PEN) Returns On Capital

Executive VP notifies of intention to sell stock

Penumbra, Inc. Announces First Patient in STORM-PE RCT Enrolled Evaluating Penumbra's Latest Computer Assisted Vacuum Thrombectomy - Lightning Flash for Treatment of Acute Pulmonary Embolism

A Look At The Fair Value Of Penumbra, Inc. (NYSE:PEN)

Now 21% undervalued after recent price drop

Penumbra, Inc. Provides Earnings Guidance for the Full Year 2023

Third quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Penumbra, Inc. Announces Latest STRIKE-PE Data Evaluating Penumbra's Indigo Aspiration System with Lightning

Price target decreased by 8.5% to US$301

Penumbra: Appeal Improves, Just Not Appealing Yet

Co-Founder exercised options and sold US$2.0m worth of stock

Now 20% undervalued after recent price drop

Penumbra, Inc. to Report Q3, 2023 Results on Nov 02, 2023

Returns On Capital Signal Tricky Times Ahead For Penumbra (NYSE:PEN)

Co-Founder exercised options and sold US$2.8m worth of stock

Executive VP notifies of intention to sell stock

Penumbra: Consolidation Does Nothing To Change Long-Term Thesis, Reiterate Buy

A Look At The Intrinsic Value Of Penumbra, Inc. (NYSE:PEN)

Co-Founder notifies of intention to sell stock

Consensus EPS estimates increase by 16%

New minor risk - Shareholder dilution

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Co-Founder exercised options and sold US$3.0m worth of stock

Penumbra, Inc. to Report Q2, 2023 Results on Aug 01, 2023

Penumbra (NYSE:PEN) Has Some Way To Go To Become A Multi-Bagger

Penumbra: Future Upside Drivers In Fundamental, Sentimental And Valuation Factors

Co-Founder exercised options and sold US$3.1m worth of stock

Executive VP notifies of intention to sell stock

Penumbra Expands Computer-Aided Thrombectomy Offerings with Lightning Bolt 7 Technology Designed to Rapidly Remove Blood Clots with Modulated Aspiration

Getting In Cheap On Penumbra, Inc. (NYSE:PEN) Might Be Difficult

Penumbra, Inc. Updates Revenue Guidance for the Full Year 2023

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

Executive VP exercised options and sold US$154k worth of stock

We're Not Worried About Penumbra's (NYSE:PEN) Cash Burn

Independent Director notifies of intention to sell stock

Executive VP notifies of intention to sell stock

Price target increased by 11% to US$291

Price target increased by 7.2% to US$272